DE3882727D1 - Mycoplasma-membran-antigene und ihre verwendung. - Google Patents

Mycoplasma-membran-antigene und ihre verwendung.

Info

Publication number
DE3882727D1
DE3882727D1 DE8888101310T DE3882727T DE3882727D1 DE 3882727 D1 DE3882727 D1 DE 3882727D1 DE 8888101310 T DE8888101310 T DE 8888101310T DE 3882727 T DE3882727 T DE 3882727T DE 3882727 D1 DE3882727 D1 DE 3882727D1
Authority
DE
Germany
Prior art keywords
membrane antigens
mycoplasma membrane
mycoplasma
antigens
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888101310T
Other languages
English (en)
Other versions
DE3882727T2 (de
Inventor
Yehudith Naot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimotech Ltd
Original Assignee
Dimotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL81489A external-priority patent/IL81489A0/xx
Priority claimed from IL83546A external-priority patent/IL83546A/xx
Application filed by Dimotech Ltd filed Critical Dimotech Ltd
Publication of DE3882727D1 publication Critical patent/DE3882727D1/de
Application granted granted Critical
Publication of DE3882727T2 publication Critical patent/DE3882727T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19883882727 1987-02-05 1988-01-29 Mycoplasma-Membran-Antigene und ihre Verwendung. Expired - Fee Related DE3882727T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL81489A IL81489A0 (en) 1987-02-05 1987-02-05 Method for the preparation of antigens to be used for the determination of antibodies
IL83546A IL83546A (en) 1987-08-14 1987-08-14 Mycoplasma membrane antigens essentially free of d.n.a.and r.n.a.,process for their preparation and kits containing them

Publications (2)

Publication Number Publication Date
DE3882727D1 true DE3882727D1 (de) 1993-09-09
DE3882727T2 DE3882727T2 (de) 1993-12-02

Family

ID=26321645

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19883882727 Expired - Fee Related DE3882727T2 (de) 1987-02-05 1988-01-29 Mycoplasma-Membran-Antigene und ihre Verwendung.

Country Status (3)

Country Link
EP (1) EP0278340B1 (de)
JP (1) JPH01257264A (de)
DE (1) DE3882727T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7212091A (en) * 1990-02-05 1991-08-21 University Of British Columbia, The Rapid immunoblot diagnosis of acute mycoplasma pneumoniae
FR2694402B1 (fr) * 1992-08-03 1994-09-30 Pasteur Institut Nouveau procédé pour la détection d'infections à mycoplasmes et son application au traitement et à la prévention du sida.
FR2696186B1 (fr) * 1992-09-28 1994-12-02 Pasteur Institut Souches de Mycoplasma. fermentans cytopathogène et procédés de diagnostic in vitro et d'immunisation mettant en Óoeuvre de telles souches.
AU4821497A (en) * 1996-10-15 1998-05-11 Enteron, L.P. Organism-specific and allergen-specific antibody capture assay and compositions for detection of disease-causing organisms and allergens
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
EP1707623A1 (de) * 2005-04-01 2006-10-04 Qiagen GmbH Reverse Transkription und Amplifikation von RNA bei simultaner Degradierung von DNA
US8309303B2 (en) 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
EP1762627A1 (de) 2005-09-09 2007-03-14 Qiagen GmbH Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
IL182958A (en) 2007-05-03 2012-04-30 Mor Research Applic Ltd Method and kit for the detection of infection with mycoplasmas of the genitals and urinary tract in a biological sample
JP5726432B2 (ja) * 2010-04-13 2015-06-03 積水メディカル株式会社 マイコプラズマ・ニューモニエ抗原測定の検出方法
ES2764481T3 (es) 2013-08-23 2020-06-03 Tauns Co Ltd Procedimiento y kit de detección inmunológica de Mycoplasma pneumoniae
CN111122861A (zh) * 2020-01-20 2020-05-08 浙江大学 一种检测血清肺炎支原体特异性IgE的试剂盒
CN112946297A (zh) * 2021-01-29 2021-06-11 中南大学湘雅三医院 一种解脲支原体感染的诊断标物及其对应的检测试剂盒的制备方法与应用
CN113817032A (zh) * 2021-09-28 2021-12-21 山东硕景生物科技有限公司 一种检测抗肺炎支原体抗体的天然抗原p1及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
AU7068587A (en) * 1986-03-27 1987-10-01 Cetus Corporation Monoclonal antibody immunoblot assay for antigens

Also Published As

Publication number Publication date
JPH01257264A (ja) 1989-10-13
EP0278340A3 (en) 1990-08-22
EP0278340B1 (de) 1993-08-04
DE3882727T2 (de) 1993-12-02
EP0278340A2 (de) 1988-08-17

Similar Documents

Publication Publication Date Title
DE3787590D1 (de) Polytetrafluoraethylenhaltige beschichtungsmasse und ihre verwendung.
PT85616A (de) Aryloxycarbonsaurederivate ihre herstellung und verwendung
DE3786205D1 (de) Titanocene und deren verwendung.
NO880395D0 (no) Antigener.
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3784199D1 (de) Titanocene und deren verwendung.
DE3880893D1 (de) Fluessige modifizierte statistische aethylencopolymere und ihre verwendung.
DE68903665T2 (de) Balg-pipette und ihre verwendung.
DE3882727D1 (de) Mycoplasma-membran-antigene und ihre verwendung.
DE3873797T2 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
DE58902272D1 (de) Substituierte naphthacen-5,12-dione und deren verwendung.
DE3881576D1 (de) Anthracyclinderivate und ihre verwendung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3688369T2 (de) Nodulationsfoerdernde bakterien und ihre verwendung.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE68919259D1 (de) N-Phenylimide, ihre Herstellung und Verwendung.
DE69009204T2 (de) Hydroxyperoxide und ihre Verwendung.
DE3883352D1 (de) Muramylpeptid-derivate und ihre verwendung.
DE58907546D1 (de) Substituierte Naphthacen-5,12-dione und deren Verwendung.
DE3868608D1 (de) Organozinn-alkoxycarbonylphenylmercaptide und deren verwendung.
DE3879328T2 (de) Stannosilikate, ihre herstellung und verwendung.
DE3888608D1 (de) Einbettzusammensetzung und ihre Verwendung.
ATE125534T1 (de) Substituierte dibenzonfurane und ihre verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee